NovaVive Inc. - Canine

Home
Canada
Napanee, ON
NovaVive Inc. - Canine

NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

10/30/2025

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further research has demonstrated that it can also be safely administered by IV injection.

Immunocidin is approved by regulators in the USA and Canada. Research is ongoing with this product in various tumor types using different administration methods.

Visit NovaVive.ca/products for more information.

10/23/2025

NovaVive is pleased to help Sophie live her best life despite a cancer diagnosis.

Four years after her diagnosis, Sophie is continuing to delight her family. Three months of Immunocidin immunotherapy contributed to this outcome.

This product is approved by regulators in the USA and Canada for the treatment of canine mammary cancer, but the Company continues to explore other cancers for which Immunocidin may be effective. One of these is bladder cancer.

Learn more about Immunocidin research at http://novavive.ca/canine-research.

10/15/2025

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.

NovaVive continues to explore other cancers for which Immunocidin may be effective. One of these is osteosarcoma (bone cancer).

Learn more about Immunocidin research at http://novavive.ca/canine-research.

10/02/2025

Cancer is the leading cause of death in senior dogs in North America. The Animcal Cancer Foundation in the U.S. estimates that approximately 6 million dogs are diagnosed with cancer in the U.S. alone each year. About 40% of these will die from the disease annually.

Immunocidin® is our regulator-approved anticancer immunotherapy for the treatment of canine mammary tumors and mammary adenocarcinoma. It is approved and available in the U.S. and Canada.

NovaVive has an ongoing program exploring other cancers for which Immunocidin may be effective. Veterinarians who are interested in exploring Immunocidin as a treatment option are in regular contact with the NovaVive technical team to consider the best approaches. Each case is unique and responds differently to therapy.

For more information, visit NovaVive.ca/products.

09/25/2025

Seeing our beloved pets reach the end of their lives is difficult. Often, there are no further treatment options and we must face losing them.

Immunocidin immunotherapy has been used as a palliative treatment to help pets stay comfortable. Ask your veterinarian about Immunocidin or visit NovaVive.ca/products for more information.

09/23/2025

Please enjoy reading the latest quarterly business update newsletter from NovaVive - Volume 11, Issue 3 - https://tinyurl.com/yjz257us

For further information, visit our website – www.NovaVive.ca.

09/18/2025

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog. Our technology helps make a tumor recognizable to the animal’s immune system.

The product is approved in the USA and Canada for treating canine mammary cancer and research is ongoing in other tumor types.

Visit NovaVive.ca/products to learn more

09/11/2025

NovaVive is pleased to help Dolly live her best life despite a cancer diagnosis. For over three-and-a-half years, Dolly has been treated with Immunocidin immunotherapy.

This product is approved by regulators in the USA and Canada for the treatment of canine mammary cancer, but the Company continues to explore other cancers for which Immunocidin may be effective. One of these is osteosarcoma (bone cancer).

Learn more about Immunocidin research at http://novavive.ca/canine-research.

08/26/2025

It's International Dog Day! NovaVive - and our canine family members - send best wishes for a happy day with your canine companion(s).🐾

08/21/2025

Kiska sadly lost her battle with cancer. However, we were glad to be able to offer support for almost one year after she started our therapy.

As her guardian says, “Kiska was my entire heart and soul and was the best dog I will ever have the privilege to know, so I am thankful for each extra minute that the Immunocidin gave me with her.”

Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including TCC.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

08/12/2025

Bama Belle sadly lost her battle with cancer. However, we were glad to be able to offer support for almost 10 months after she started our therapy.

As her guardian says, “I believe we were blessed with more time because of you and Immunocidin. I am eternally grateful for everything you provided during this difficult period.”

Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Website

http://www.NovaVive.ca/

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NovaVive Inc. - Canine:

Shortcuts

Want your practice to be the top-listed Clinic in Napanee?